KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aramark (ARMK) Asset Writedowns and Impairment (2020 - 2026)

Aramark (ARMK) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $6.1 million as the latest value for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $6.1 million in Q1 2026 year-over-year; TTM through Jan 2026 was $24.2 million, a 33.31% increase, with the full-year FY2025 number at $8.9 million, down 50.81% from a year prior.
  • Asset Writedowns and Impairment was $6.1 million for Q1 2026 at Aramark, down from $18.2 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $18.3 million in Q4 2022 to a low of $2.1 million in Q3 2023.
  • A 4-year average of $10.8 million and a median of $9.5 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 772.65% in 2024; the steepest drop was 772.65% in 2024.
  • Aramark's Asset Writedowns and Impairment stood at $18.3 million in 2022, then plummeted by 88.62% to $2.1 million in 2023, then skyrocketed by 772.65% to $18.2 million in 2024, then crashed by 66.69% to $6.1 million in 2026.
  • Per Business Quant, the three most recent readings for ARMK's Asset Writedowns and Impairment are $6.1 million (Q1 2026), $18.2 million (Q3 2024), and $2.1 million (Q3 2023).